HR Execs on the Move


 
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of CNS disorders. Axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. The company is based in New York City.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.axsome.com
  • 200 Broadway 3rd Floor
    New York, NY USA 10004
  • Phone: 212.332.3241

Executives

Name Title Contact Details
Rachel Fisher
Director, Marketing Profile

Similar Companies

Leap Therapeutics

Leap is developing novel drugs to change the practice of cancer medicine

MBX Biosciences

MBX Biosciences is a preclinical-stage biotechnology company using validated molecular targets to create medicines for rare endocrine diseases where current therapies are inadequate.

Nutripro Biosystems

Nutripro Biosystems is a Worthington, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wheeler Bio

A disruptive new biopharmaceutical CDMO, we are pushing the boundaries of biomanufacturing and solving an outdated industry bottleneck with a unique partnering model. By bringing together biologics drug innovators, discovery CROs, and CDMOs, we are accelerating the translation of therapeutic innovation to clinical impact.

DEKA Research and Development Corporation

DEKA Research and Development Corporation is a Manchester, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.